New global campaign to make preventable disease history launched today by the Global Health Security Consortium.
One Shot roadmap sets out how this can be done – building on the response to Covid-19 and capitalising on the potential of next-generation vaccines and injectable therapeutics.
Governments, industry and global health organisations urged to come together to realise this vision as leaders and representatives prepare to attend the World Health Summit in Berlin.
One Shot: Making Preventable Disease History is the goal of a new campaign launched today by the Global Health Security Consortium (GHSC) – a partnership between the Tony Blair Institute for Global Change, the Ellison Institute for Transformative Medicine and the University of Oxford, alongside a roadmap setting out how this can be achieved.
The response to Covid-19 saw huge advancements in the development of life-saving vaccines. One Shot seeks to build on these by creating a roadmap to transform global health infrastructure – driving the shift towards preventative health and bolstering preparedness for future pandemics. This means harnessing the potential and demand for next-generation vaccines to tackle diseases such as dengue, human papillomavirus, malaria, respiratory syncytial virus and tuberculosis, as well as novel injectable prophylactics for conditions including heart disease and HIV.
The potential rewards are huge in terms of lives saved and life expectancy prolonged. At least 10 million deaths a year are attributable to diseases with existing or imminent adult vaccines and preventable injectable therapies. This includes non-communicable diseases (NCDs) such as cardiovascular and respiratory diseases, cancer and diabetes: collectively responsible for over 70 per cent of deaths worldwide.